➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Custirsen

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Custirsen?

Custirsen is an investigational drug.

There have been 12 clinical trials for Custirsen. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Lung Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are OncoGenex Technologies, NCIC Clinical Trials Group, and Teva Pharmaceutical Industries.

Recent Clinical Trials for Custirsen
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationTeva Pharmaceutical IndustriesPhase 1
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationOncoGenex TechnologiesPhase 1
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerOncoGenex TechnologiesPhase 3

See all Custirsen clinical trials

Clinical Trial Summary for Custirsen

Top disease conditions for Custirsen
Top clinical trial sponsors for Custirsen

See all Custirsen clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.